CLIENT FEATURE: Molecule Holdings (MLCL: CSE) is Pioneering the Cannabis Craft-Beverage Market
posted on
Mar 04, 2021 03:30PM
6 Months ending April '23, Revenue was 558K CAD
Why Molecule?
Revenue Forecast:
The Facility:
Molecule currently holds a Standard Processing Licence issued by Health Canada, which allows it to manufacture cannabis-infused products and sell them to other Licenced Producers
The company’s recent partnership with Vortex Cannabis Inc. allows Molecule to bring its unique line of cannabis-infused beverage products to market in 2021, while completing its own sales amendment application, which will allow it to sell to provincial wholesalers directly.
NEWSFLASH:
FULL DISCLOSURE: Molecule is an advertising client of AGORA Internet Relations Corp.